Publications (95) MERCEDES ALPERI LOPEZ publications

filter_list

2025

  1. Golimumab retention in patients with psoriatic arthritis and axial spondyloarthritis: evidence from up to a decade of follow-up

    Expert Review of Clinical Pharmacology

  2. Psoriatic arthritis phenotype may vary depending on whether the skin or joint domain appears first or whether both appear simultaneously

    Clinical and experimental rheumatology, Vol. 43, Núm. 5, pp. 889-896

  3. Study of the impact of the inclusion of global pain and functional capacity assessment in the definition of remission and its maintenance for rheumatoid arthritis. Aims and methodology

    Reumatologia Clinica, Vol. 21, Núm. 5

2024

  1. Do the Activity Indices Used in Axial Spondyloarthritis Capture the Relationships Between Obesity, Smoking and Disease Activity in the Same Way?

    Journal of Clinical Medicine, Vol. 13, Núm. 22

  2. Searching for a Novel HLA-Cw6-Linked Cardiometabolic Endotype in Psoriatic Disease

    Biomedicines, Vol. 12, Núm. 10

  3. Seven-chain adaptive immune receptor repertoire analysis in rheumatoid arthritis reveals novel features associated with disease and clinically relevant phenotypes

    Genome Biology, Vol. 25, Núm. 1

2023

  1. Acroosteolysis and facial dysmorphia: a new case of Hajdu-Cheney Syndrome

    Reumatologia Clinica, Vol. 19, Núm. 9, pp. 527-529

  2. Are Patients with Axial Spondyloarthritis Who Were Breastfed Protected against the Development of Severe Disease?

    Journal of Clinical Medicine, Vol. 12, Núm. 5

  3. Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stages

    Rheumatology (Oxford, England), Vol. 62, Núm. 8, pp. 2898-2907

  4. Managing psoriatic arthritis in different clinical scenarios

    Expert Review of Clinical Immunology, Vol. 19, Núm. 12, pp. 1469-1484

  5. Treatment Retention and Safety of Ixekizumab in Psoriatic Arthritis: A Real Life Single-Center Experience

    Journal of Clinical Medicine, Vol. 12, Núm. 2

2022

  1. Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis

    Reumatologia Clinica, Vol. 18, Núm. 1, pp. 33-41

  2. Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis

    eBioMedicine, Vol. 80

  3. Non-Physical Disease Facets in Spondyloarthritis: An ASAS Health Index-Based Analysis between Psoriatic Arthritis and Axial Spondyloarthritis

    Journal of Clinical Medicine, Vol. 11, Núm. 20

  4. The ASAS Health Index: A New Era for Health Impact Assessment in Spondyloarthritis

    The Journal of rheumatology, Vol. 49, Núm. 1, pp. 8-15

2021

  1. ASAS health index as an addition to routine clinical practice

    Journal of Rheumatology

  2. Dietary habits in patients with fibromyalgia: a cross-sectional study

    Clinical and experimental rheumatology, Vol. 39, Núm. 3, pp. 170-173

  3. Do NSAIDs Take Us Away From Treatment Goals in Axial Spondyloarthritis: A Story About Dysbiosis or Just a Matter of Bias?

    Frontiers in Medicine, Vol. 8

  4. Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study

    European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382

  5. HLA–B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti–Carbamylated Protein Antibody–Positive/Anti–Cyclic Citrullinated Peptide–Negative Rheumatoid Arthritis

    Arthritis and Rheumatology, Vol. 73, Núm. 6, pp. 963-969